Sinequan and Strattera
Determining the interaction of Sinequan and Strattera and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:The concomitant administration of atomoxetine with drugs that affect norepinephrine (e.g., norepinephrine reuptake inhibitors) may theoretically result in additive or synergistic pharmacologic effects. The clinical significance is unknown. Caution is advisable if these drugs are used together.
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Multum Information Services, Inc. Expert Review Panel"
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sinequan-Streptase
- Sinequan-Streptokinase Intravenous, Intracoronary
- Sinequan-Streptomycin
- Sinequan-Streptomycin Intramuscular
- Sinequan-Streptomycin Sulfate
- Sinequan-Streptozocin
- Strattera-Sinequan (Doxepin Capsules)
- Strattera-Sinequan (Doxepin Oral Concentrate)
- Strattera-Sinex Long-Acting
- Strattera-Sinex Nasal Spray
- Strattera-Singulair
- Strattera-Singulair (Montelukast Chewable Tablets)